P
Philippe Rochigneux
Researcher at Aix-Marseille University
Publications - 43
Citations - 564
Philippe Rochigneux is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 28 publications receiving 330 citations. Previous affiliations of Philippe Rochigneux include University of California, Los Angeles & University Hospital of Lausanne.
Papers
More filters
Journal ArticleDOI
PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review.
Gabrielle Planes-Laine,Philippe Rochigneux,François Bertucci,Anne-Sophie Chretien,Patrice Viens,Renaud Sabatier,Anthony Gonçalves +6 more
TL;DR: In this review, the results of the most recent studies evaluating immune checkpoint inhibitors in breast cancer are reported and the concomitant development of possible biomarkers, which is required for improving the selection of patients with the highest probability of benefiting from these agents are discussed.
Journal ArticleDOI
Use of chemotherapy near the end of life: what factors matter?
Philippe Rochigneux,Jean-Luc Raoul,Yvan Beaussant,Régis Aubry,F. Goldwasser,Christophe Tournigand,Lucas Morin +6 more
TL;DR: Among hospitalized patients with cancer, young individuals, treated in comprehensive cancer centers or in high-volume centers without palliative care units were the most likely to receive chemotherapy near the end of life, and there was no obvious pattern between the expected chemosensitivity of different cancers and the rates of chemotherapy use close to death.
Journal ArticleDOI
Hospital end-of-life care in haematological malignancies
Yvan Beaussant,Etienne Daguindau,Adrien Chauchet,Philippe Rochigneux,Christophe Tournigand,Régis Aubry,Lucas Morin +6 more
TL;DR: A high proportion of patients who died from haematological malignancies receive specific treatments near the end of life, suggesting a need for a better and earlier integration of the palliative care approach in the standard practice of haem atology.
Journal ArticleDOI
Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials.
Philippe Rochigneux,Brice Chanez,Bernadette De Rauglaudre,Emmanuel Mitry,Christian Chabannon,Marine Gilabert +5 more
TL;DR: This review explains the concept of TCR modified and CAR-T cells in liver cancer (targets and mechanisms of action) and reports the results from recent clinical trials.
Journal ArticleDOI
Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors.
Marjorie Faure,Philippe Rochigneux,Philippe Rochigneux,Daniel Olive,Sébastien Taix,Isabelle Brenot-Rossi,Marine Gilabert +6 more
TL;DR: A 77-year-old male metastatic anorectal melanoma patient presenting with HPD over 2 months of a PD1 inhibitor treatment course is reported and this HPD blood phenotype is documented.